Microvascular and systemic effects following top load administration of saturated carbon monoxide-saline solution

Critical Care Medicine

Volumn 35, Issue 4, 2007, Pages 1123-1132

  Hangai Hoger, Nanae ^a   Tsai, Amy G ^a,b   Cabrales, Pedro ^b   Suematsu, Makoto ^c   Intaglietta, Marcos ^a,b  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^b LA JOLLA BIOENGINEERING INSTITUTE   (United States)

^c KEIO UNIVERSITY   (Japan)

Author keywords

Carbon monoxide; Cardiac output; Cyclic guanosine monophosphate; Hamster window model; Microcirculation; Vasodilatation

Indexed keywords

1H 1,2,4 OXADIAZOLO[4,3 A]QUINOXALIN 1 ONE; CARBON MONOXIDE; CYCLIC GMP; N(G) NITROARGININE METHYL ESTER; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERIAL GAS; ARTERIOLE; ARTICLE; BLOOD VOLUME; CAPILLARY DENSITY; CONTROLLED STUDY; ENZYME IMMUNOASSAY; ERYTHROCYTE; HEART INDEX; HEART OUTPUT; HEART RATE; HEMODYNAMICS; LABORATORY TEST; MALE; MEAN ARTERIAL PRESSURE; MEASUREMENT; MICROCIRCULATION; MICROVASCULATURE; NONHUMAN; PRIORITY JOURNAL; PROSPECTIVE STUDY; SKINFOLD; VENULE;

EID: 34247165440     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.CCM.0000259533.84180.C7     Document Type: Article

References (51)

1. Kanten WE, Penney DG, Francisco K, et al: Hemodynamic responses to acute carboxyhemoglobinemia in the rat. Am J Physiol 1983; 244:H320-H327
2. Gutierrez G, Rotman HH, Reid CM, et al: Comparison of canine cardiovascular response to inhaled and intraperitoneally infused CO. J Appl Physiol 1985; 58:558-563
3. Kerger H, Saltzman DJ, Menger MD, et al: Systemic and subcutaneous microvascular pO2 dissociation during 4-h hemorrhagic shock in conscious hamsters. Am J Physiol 1996; 270:H827-H836
4. Endrich B, Asaishi K, Götz A, et al: Technical report: A new chamber technique for microvascular studies in unanaesthetized hamsters. Res Exp Med 1980; 177:125-134
5. Intaglietta M, Silverman NR, Tompkins WR: Capillary flow velocity measurements in vivo and in situ by television methods. Microvasc Res 1975; 10:165-179
6. Lipowsky HH, Zweifach BW: Application of the "two-slit" photometric technique to the measurement of microvascular volumetric flow rates. Microvasc Res 1978; 15:93-101
7. Intaglietta M, Tompkins WR: Microvascular measurements by video image shearing and splitting. Microvasc Res 1973; 5:309-312
8. American College of Physicians: Practice Strategies for Elective Red Blood Cell Transfusion. Vol. 116. American College of Physicians, 1992
9. Parks J, Worth HGJ: Carboxyhemoglobin Determination by Second-Derivative Spectroscopy. Clin Chem 1985; 31:279-281
10. Cabrales P, Acero C, Intaglietta M, et al: Measurement of the cardiac output in small animals by thermodilution. Microvasc Res 2003; 66:77-82
11. Sakai H, Hara H, Tsai AG, et al: Constriction of resistance arteries determines L-NAME-induced hypertension in a conscious hamster model. Microvasc Res 2000; 60:21-27
12. Gimeno G, Carpentier PH, Desquand-Billiald S, et al: L-arginine and NG-nitro-L-arginine methyl ester cause macromolecule extravasation in the microcirculation of awake hamsters. Eur J Pharmacol 1998; 346:275-282
13. Panzali A, Signorini C, Albertini A: Improvement in lower carboxyhemoglobin range determination by second-derivative spectroscopy. Clin Chem 1987; 33:2311-2312
14. Guo Y, Stein AB, Wu WJ, et al: Administration of a CO-releasing molecule at the time of reperfusion reduces infarct size in vivo. Am J Physiol Heart Circ Physiol 2004; 286:H1649-H1653
15. Thorup C, Jones CL, Gross SS, et al: Carbon monoxide induces vasodilation and nitric oxide release but suppresses endothelial NOS. Am J Physiol 1999; 277:F882-F889
16. Kajimura M, Goda N, Suematsu M: Organ design for generation and reception of CO: Lessons from the liver. Antioxid Redox Signal 2002; 4:633-637
17. Imai T, Morita T, Shindo T, et al: Vascular smooth muscle cell-directed overexpression of heme oxygenase-1 elevates blood pressure through attenuation of nitric oxide-induced vasodilation in mice. Circ Res 2001; 89:55-62
18. Klatt P, Schmidt K, Mayer B: Brain nitric oxide synthase is a haemoprotein. Biochem J 1992; 288:15-17
19. Matsuoka A, Stuehr DJ, Olson JS, et al: L-arginine and calmodulin regulation of the heme iron reactivity in neuronal nitric oxide synthase. J Biol Chem 1994; 269:20335-20339
20. McMillan K, Masters BS: Prokaryotic expression of the heme- and flavin-binding domains of rat neuronal nitric oxide synthase as distinct polypeptides: Identification of the heme-binding proximal thiolate ligand as cysteine-415. Biochemistry 1995; 34:3686-3693
21. Pufahl RA, Marletta MA: Oxidation of NG-hydroxy-L-arginine by nitric oxide synthase: evidence for the involvement of the heme in catalysis. Biochem Biophys Res Commun 1993; 193:963-970
22. White KA, Marletta MA: Nitric oxide synthase is a cytochrome P-450 type hemoprotein. Biochemistry 1992; 31:6627-6631
23. Johnson RA, Kozma F, Colombari E: Carbon monoxide: from toxin to endogenous modulator of cardiovascular functions. Braz J Med Biol Res 1999; 32:1-14
24. Willis D, Tomlinson A, Frederick R, et al: Modulation of heme oxygenase activity in rat brain and spleen by inhibitors and donors of nitric oxide. Biochem Biophys Res Commun 1995; 214:1152-1156
25. Durante W, Kroll MH, Christodoulides N, et al: Nitric oxide induces heme oxygenase-1 gene expression and carbon monoxide production in vascular smooth muscle cells. Circ Res 1997; 80:557-564
26. Ischiropoulos H, Beers MF, Ohnishi ST, et al: Nitric oxide production and perivascular nitration in brain after carbon monoxide poisoning in the rat. J Clin Invest 1996; 97:2260-2267
27. Fan B, Wang J, Stuehr DJ, et al: NO synthase isozymes have distinct substrate binding sites. Biochemistry 1997; 36:12660-12665
28. McMillan K, Bredt DS, Hirsch DJ, et al: Cloned, expressed rat cerebellar nitric oxide synthase contains stoichiometric amounts of heme, which binds carbon monoxide. Proc Natl Acad Sci U S A 1992; 89:11141-11145
29. Ishikawa M, Kajimura M, Adachi T, et al: Carbon monoxide from heme oxygenase-2 Is a tonic regulator against NO-dependent vasodilatation in the adult rat cerebral microcirculation. Circ Res 2005; 97:e104-e114
30. Clark JE, Naughton P, Shurey S, et al: Cardioprotective actions by a water-soluble carbon monoxide-releasing molecule. Circ Res 2003; 93:e2-e8
31. Nishikawa Y, Stepp DW, Merkus D, et al: In vivo role of heme oxygenase in ischemic coronary vasodilation. Am J Physiol Heart Circ Physiol 2004; 286:H2296-H2304
32. Schmidt HH: NO, CO and OH. Endogenous soluble guanylyl cyclase-activating factors. FEBS Lett 1992; 307:102-107
33. Graser T, Vedernikov YP, Li DS: Study on the mechanism of carbon monoxide induced endothelium-independent relaxation in porcine coronary artery and vein. Biomed Biochim Acta 1990; 49:293-296
34. Marks GS, Brien JF, Nakatsu K, et al: Does carbon monoxide have a physiological function? Trends Pharmacol Sci 1991; 12:185-188
35. Kharitonov VG, Sharma VS, Magde D, et al: Kinetics and equilibria of soluble guanylate cyclase ligation by CO: effect of YC-1. Biochemistry 1999; 38:10699-10706
36. Furchgott RF, Jothianandan D: Endothelium-dependent and -independent vasodilation involving cyclic GMP: relaxation induced by nitric oxide, carbon monoxide and light. Blood Vessels 1991; 28:52-61
37. Moro MA, Russel RJ, Cellek S, et al: cGMP mediates the vascular and platelet actions of nitric oxide: confirmation using an inhibitor of the soluble guanylyl cyclase. Proc Natl Acad Sci U S A 1996; 93:1480-1485
38. Cechova S, Pajewski TN: The soluble guanylyl cyclase inhibitor ODQ, 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one, dose-dependently reduces the threshold for isoflurane anesthesia in rats. Anesth Analg 2004; 99:752-757
39. Wang R, Wu L, Wang Z: The direct effect of carbon monoxide on KCa channels in vascular smooth muscle cells. Pflugers Arch 1997; 434:285-291
40. Coceani F: Control of the ductus arteriosus - A new function for cytochrome P450, endothelin and nitric oxide. Biochem Pharmacol 1994; 48:1315-1318
41. Estabrook RW, Franklin MR, Hildebrandt AG: Factors influencing the inhibitory effect of carbon monoxide on cytochrome P-450-catalyzed mixed function oxidation reactions. Ann N Y Acad Sci 1970; 174:218-232
42. Bolotina VM, Najibi S, Palacino JJ, et al: Nitric oxide directly activates calcium-dependent potassium channels in vascular smooth muscle. Nature 1994; 368:850-853
43. Trottier G, Triggle CR, O'Neill SK, et al: Cyclic GMP-dependent and cyclic GMP-independent actions of nitric oxide on the renal afferent arteriole. Br J Pharmacol 1998; 125:563-569
44. Tsai AG, Acero C, Nance PR, et al: Elevated plasma viscosity in extreme hemodilution increases perivascular nitric oxide concentration and microvascular perfusion. Am J Physiol Heart Circ Physiol 2005; 288:H1730-H1739
45. Hangai-Hoger N, Nacharaju P, Manjula BN, et al: Microvascular effects following treatment with polyethylene glycol-albumin in lipopolysaccharide- induced endotoxemia. Crit Care Med 2006; 34:108-117
46. Ingi T, Cheng J, Ronnett GV: Carbon monoxide: An endogenous modulator of the nitric oxide-cyclic GMP signaling system. Neuron 1996; 16:835-842
47. Stamler JS, Piantadosi CA: O=O NO: It's CO. J Clin Invest 1996; 97:2165-2166
48. Fujimoto H, Ohno M, Ayabe S, et al: Carbon monoxide protects against cardiac ischemia-reperfusion injury in vivo via MAPK and Akt-eNOS pathways. Arterioscler Thromb Vasc Biol 2004; 24:1848-1853
49. Mazzola S, Forni M, Albertini M, et al: Inhaled carbon monoxide (CO) prevents lung oedema induced by endotoxic shock. Vet Res Commun 2004; 28(Suppl 1):209-212
50. Guo R, Gao XY, Wang W, et al: Tempol reduces reperfusion-induced arrhythmias in anaesthetized rats. Pharmacol Res 2005; 52:192-198
51. Stein AB, Guo Y, Tan W, et al: Administration of a CO-releasing molecule induces late preconditioning against myocardial infarction. J Mol Cell Cardiol 2005; 38:127